Article Versions Notes

Oiki H, Suda K, Hamada A, Fujino T, Obata K, Kobayashi Y, Sakai K, Fukuda S, Ohara S, Ito M, et al. Efficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon EGFR Mutations—An In Vitro Study. Cells. 2025; 14(17):1386. https://doi.org/10.3390/cells14171386

Oiki, Hana, Kenichi Suda, Akira Hamada, Toshio Fujino, Keiko Obata, Yoshihisa Kobayashi, Kazuko Sakai, Shota Fukuda, Shuta Ohara, Masaoki Ito, and et al. 2025. "Efficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon EGFR Mutations—An In Vitro Study" Cells 14, no. 17: 1386. https://doi.org/10.3390/cells14171386

Oiki, H., Suda, K., Hamada, A., Fujino, T., Obata, K., Kobayashi, Y., Sakai, K., Fukuda, S., Ohara, S., Ito, M., Soh, J., Nishio, K., Mitsudomi, T., & Tsutani, Y. (2025). Efficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon EGFR Mutations—An In Vitro Study. Cells, 14(17), 1386. https://doi.org/10.3390/cells14171386